Comprehensive Analysis
To establish today's starting point, we look directly at where the market is pricing Teradyne right now: As of May 31, 2026, Close $382.65. At this price level, and with roughly 156.00M shares outstanding, the company commands a massive market capitalization of approximately $59.7B. The stock is currently trading in the absolute upper third of its 52-week range, reflecting a relentless surge in buying momentum throughout the year. When attempting to value a technology hardware company of this size, retail investors should focus on a few key metrics that cut through the noise: the Forward P/E ratio sits at roughly 61.1x (assuming next year's earnings hit highly optimistic estimates), the Forward EV/EBITDA multiple is around 45.0x, the Forward FCF Yield is a very slim 2.0%, and the Forward Dividend Yield is barely visible at 0.13%. As noted in prior category analyses, Teradyne boasts an incredibly protective moat, elite cash conversion, and a deeply entrenched position in next-generation AI chip testing, which easily justifies a premium valuation. However, understanding that a business is wonderful is only half the battle; the numbers currently on the screen tell us exactly how much of that wonderful future is already baked into today's premium price tag. When we check the market consensus to see what the professional crowd thinks it is worth, we must look at 12-month analyst price targets. Currently, Wall Street analysts have established a Low $250 / Median $375 / High $476 range for Teradyne. If we measure today's stock price against the median expectation, the Implied upside/downside vs today's price is actually negative, sitting at -2.0%. This indicates that the stock has essentially overrun the average analyst's near-term expectations. Furthermore, the Target dispersion—the gap between the highest and lowest guesses—is extremely Wide, spanning $226. In simple words, analyst price targets represent Wall Street's sentiment based on complex models of future growth, margins, and industry cycles. They are notoriously reactive, meaning analysts frequently raise their targets only after the stock price has already gone up, rather than predicting the move beforehand. A wide dispersion like we see here tells us that there is a severe lack of agreement on how long the current AI infrastructure boom will last. The low target models a rapid digestion phase where chipmakers pause their spending, while the high target assumes a multi-year super-cycle. Retail investors must remember that analyst targets are not the undeniable truth; they are simply an anchor of market expectations that can quickly unravel if growth slows down. To look past the noise of Wall Street sentiment, we must calculate the intrinsic value of the business using a basic Discounted Cash Flow (DCF) framework. This method asks a very simple question: if you owned this entire company privately, how much cash would it put in your pocket over its lifetime, and what is that cash worth today? For our assumptions, we will use a highly optimistic starting FCF (FY2026E) of $1.2B to give the company full credit for its recent explosive AI order momentum. Because AI testing is a powerful secular tailwind, we will apply an aggressive FCF growth (3-5 years) rate of 18.0%. Afterward, we assume the business matures into a steady-state/terminal growth rate of 3.5%. To account for the risk of owning a stock in a naturally cyclical industry, we apply a required return/discount rate range of 8.0%–9.5%. Running these numbers, we arrive at a fair value range of FV = $260–$335. The logic here is straightforward: if cash grows at this blistering pace, the business is intrinsically worth significantly more than it was a few years ago. However, even with these incredibly generous growth assumptions, the resulting intrinsic value is still far below the current trading price. The market is pricing in a scenario where Teradyne never experiences another cyclical downturn again. As a reality check, we can cross-reference our DCF findings by translating free cash flow and dividends into simple yields. Retail investors understand yields perfectly: if you put money in a savings account, you expect a percentage return every year. When you buy a stock, the underlying cash the business generates against the price you paid is your "yield." Today, Teradyne offers a Forward FCF Yield of roughly 2.0%, while its Forward Dividend Yield sits at an anemic 0.13%. Even if we factor in the company's aggressive share buybacks to calculate a "shareholder yield" (dividends plus buybacks), the massive $59.7B market cap heavily dilutes the actual percentage return to the investor. If we demand a standard required yield of 3.5%–5.0% to justify the risks of holding a cyclical hardware manufacturer, we can calculate a fair value simply by dividing our $1.2B forward cash flow by that target rate. This gives us a yield-based fair value range of FV = $153–$342, with a more realistic midpoint closer to $200. Ultimately, these yields suggest the stock is profoundly expensive today. You are paying top-dollar for cash flows that, as a percentage of your investment, yield less than a risk-free government bond. Moving to historical comparisons, we must ask if the stock is cheap or expensive compared to its own past. To do this, we look at the core price-to-earnings multiple. Teradyne currently trades at a Forward P/E of 61.1x (based on an estimated next-twelve-months EPS of $6.26). If we look backward, the company's 3-5 year average P/E historically lived in a much more grounded range of 25.0x–30.0x. This is a classic example of "multiple expansion." The stock price hasn't just gone up because earnings grew; it has gone up primarily because investors are suddenly willing to pay twice as much for every single dollar of those earnings. When a stock trades this far above its historical norm, it means the current price already assumes a flawless, hyper-growth future. If Teradyne reports an incredible quarter, the stock may barely move because perfection is already expected. Conversely, if growth normalizes or the AI narrative cools, the multiple could easily violently contract back toward its 30.0x average, causing massive losses for investors who buy today. Next, we must evaluate whether Teradyne is expensive compared to its closest competitors. For this peer group, we look at direct ATE (Automated Test Equipment) rivals like Advantest, Cohu, and FormFactor. When we aggregate their data, the peer median Forward EV/EBITDA multiple is roughly 30.0x. In stark contrast, Teradyne trades at a Forward EV/EBITDA of roughly 45.0x. Similarly, the peer median Forward P/E hovers around 35.0x, vastly lower than Teradyne's 61.1x. If we applied the peer median P/E multiple to Teradyne's estimated earnings, it yields an Implied Price = $200–$250. Why does Teradyne command such a massive premium over its peers? As noted in the prior analysis, Teradyne operates essentially as a monopoly in the logic/compute testing space and features vastly superior operating margins. A premium is absolutely justified by the strength of its balance sheet and its deep integration with top-tier chipmakers. However, a premium of this sheer magnitude—nearly double the peer average—moves past fundamental justification and straight into speculative hype territory. Finally, we must triangulate these distinct signals into one cohesive conclusion for the retail investor. Our valuation methods produced the following outcomes: an Analyst consensus range of $250–$476, an Intrinsic/DCF range of $260–$335, a Yield-based range of $153–$342, and a Multiples-based range of $200–$250. Because analyst targets are heavily influenced by momentum and yield metrics can be overly harsh on growth stocks, we place the highest trust in the Intrinsic/DCF range and the Multiples-based comparisons. Blending these together, we establish a Final FV range = $260–$335; Mid = $298. When we compare the Price $382.65 vs FV Mid $298 → Upside/Downside = -22.1%, the verdict is clear: the stock is currently Overvalued. For retail investors looking for entry points, the Buy Zone is strictly < $250, a Watch Zone exists between $250–$290, and the current levels place it firmly in the Wait/Avoid Zone at > $290. From a sensitivity standpoint, if we shock the model with a discount rate ±100 bps, the Revised FV midpoints = $240 / $380, showing that the discount rate is the most sensitive driver of value here. The reality check is impossible to ignore: the stock has rallied tremendously in early 2026, driven almost entirely by AI hype and forward guidance revisions. While the fundamental execution of the business is elite, the valuation has simply become detached from the mathematical reality of its underlying cash flows.